Cargando…
Nabilone treatment for severe behavioral problems in adults with intellectual and developmental disabilities: Protocol for a phase I open-label clinical trial
Severe behavioral problems (SBPs) are common contributors to morbidity and reduced quality of life for adults with intellectual and developmental disabilities (IDD) and their families. Current medications for SBPs show equivocal effectiveness and are associated with a high risk of side effects. New...
Autores principales: | Lin, Hsiang-Yuan, Abi-Jaoude, Elia, Desarkar, Pushpal, Wang, Wei, Ameis, Stephanie H., Lai, Meng-Chuan, Lunsky, Yona, Rajji, Tarek K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10096227/ https://www.ncbi.nlm.nih.gov/pubmed/37043511 http://dx.doi.org/10.1371/journal.pone.0282114 |
Ejemplares similares
-
Metformin for the treatment of antipsychotic-induced metabolic disturbances in people with intellectual and developmental disabilities
por: Stogios, Nicolette, et al.
Publicado: (2023) -
Assessing and Stabilizing Aberrant Neuroplasticity in Autism Spectrum Disorder: The Potential Role of Transcranial Magnetic Stimulation
por: Desarkar, Pushpal, et al.
Publicado: (2015) -
Roadblocks and detours on pathways to a clinical diagnosis of autism
for girls and women: A qualitative secondary analysis
por: Hamdani, Yani, et al.
Publicado: (2023) -
Antipsychotic Use With and Without Comorbid Psychiatric Diagnosis Among Adults with Intellectual and Developmental Disabilities
por: Lunsky, Yona, et al.
Publicado: (2017) -
Virtual health care for adult patients with intellectual and developmental disabilities: A scoping review
por: Selick, Avra, et al.
Publicado: (2021)